nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Dacarbazine—muscle cancer	0.334	0.441	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—muscle cancer	0.164	0.216	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—muscle cancer	0.122	0.161	CbGbCtD
Sulfadiazine—CYP3A4—Vincristine—muscle cancer	0.0541	0.0714	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—muscle cancer	0.0496	0.0654	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—muscle cancer	0.0338	0.0446	CbGbCtD
Sulfadiazine—Muscle contracture—Dactinomycin—muscle cancer	0.0223	0.0922	CcSEcCtD
Sulfadiazine—Necrolysis epidermal—Etoposide—muscle cancer	0.011	0.0455	CcSEcCtD
Sulfadiazine—Skin necrosis—Etoposide—muscle cancer	0.00715	0.0295	CcSEcCtD
Sulfadiazine—Necrolysis epidermal—Methotrexate—muscle cancer	0.00659	0.0272	CcSEcCtD
Sulfadiazine—Eruption—Dactinomycin—muscle cancer	0.00561	0.0232	CcSEcCtD
Sulfadiazine—Reaction gastrointestinal—Methotrexate—muscle cancer	0.00448	0.0185	CcSEcCtD
Sulfadiazine—Skin necrosis—Methotrexate—muscle cancer	0.00428	0.0177	CcSEcCtD
Sulfadiazine—Anuria—Methotrexate—muscle cancer	0.00428	0.0177	CcSEcCtD
Sulfadiazine—Neuritis—Vincristine—muscle cancer	0.00413	0.0171	CcSEcCtD
Sulfadiazine—Anuria—Doxorubicin—muscle cancer	0.00371	0.0153	CcSEcCtD
Sulfadiazine—Skin necrosis—Doxorubicin—muscle cancer	0.00371	0.0153	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Dactinomycin—muscle cancer	0.00324	0.0134	CcSEcCtD
Sulfadiazine—Sepsis—Dactinomycin—muscle cancer	0.00299	0.0124	CcSEcCtD
Sulfadiazine—Skin discolouration—Etoposide—muscle cancer	0.00276	0.0114	CcSEcCtD
Sulfadiazine—Polyuria—Vincristine—muscle cancer	0.00255	0.0105	CcSEcCtD
Sulfadiazine—Eruption—Methotrexate—muscle cancer	0.00243	0.01	CcSEcCtD
Sulfadiazine—Skin exfoliation—Etoposide—muscle cancer	0.00238	0.00985	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00226	0.00932	CcSEcCtD
Sulfadiazine—Sepsis—Etoposide—muscle cancer	0.00217	0.00895	CcSEcCtD
Sulfadiazine—Burning sensation—Methotrexate—muscle cancer	0.00215	0.0089	CcSEcCtD
Sulfadiazine—Eruption—Doxorubicin—muscle cancer	0.00211	0.0087	CcSEcCtD
Sulfadiazine—Ataxia—Vincristine—muscle cancer	0.0021	0.00869	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00191	0.00791	CcSEcCtD
Sulfadiazine—Stomatitis—Dactinomycin—muscle cancer	0.00188	0.00777	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Etoposide—muscle cancer	0.00187	0.00774	CcSEcCtD
Sulfadiazine—Burning sensation—Doxorubicin—muscle cancer	0.00186	0.0077	CcSEcCtD
Sulfadiazine—Agranulocytosis—Dactinomycin—muscle cancer	0.0018	0.00744	CcSEcCtD
Sulfadiazine—Neuritis—Doxorubicin—muscle cancer	0.00173	0.00717	CcSEcCtD
Sulfadiazine—Hepatitis—Dactinomycin—muscle cancer	0.00173	0.00716	CcSEcCtD
Sulfadiazine—Depression—Vincristine—muscle cancer	0.00172	0.00711	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Vincristine—muscle cancer	0.00169	0.00698	CcSEcCtD
Sulfadiazine—Stomatitis—Vincristine—muscle cancer	0.00168	0.00695	CcSEcCtD
Sulfadiazine—Skin discolouration—Methotrexate—muscle cancer	0.00166	0.00684	CcSEcCtD
Sulfadiazine—Erythema multiforme—Dactinomycin—muscle cancer	0.00164	0.00677	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00163	0.00675	CcSEcCtD
Sulfadiazine—Oliguria—Methotrexate—muscle cancer	0.00162	0.00671	CcSEcCtD
Sulfadiazine—Chills—Dactinomycin—muscle cancer	0.00155	0.00642	CcSEcCtD
Sulfadiazine—Blood disorder—Doxorubicin—muscle cancer	0.00155	0.00641	CcSEcCtD
Sulfadiazine—Hallucination—Vincristine—muscle cancer	0.00154	0.00636	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—muscle cancer	0.00143	0.00593	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methotrexate—muscle cancer	0.00143	0.0059	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—muscle cancer	0.00141	0.00581	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Methotrexate—muscle cancer	0.0014	0.0058	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00139	0.00572	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Etoposide—muscle cancer	0.00137	0.00566	CcSEcCtD
Sulfadiazine—Stomatitis—Etoposide—muscle cancer	0.00136	0.00563	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—muscle cancer	0.00135	0.00558	CcSEcCtD
Sulfadiazine—Agranulocytosis—Etoposide—muscle cancer	0.0013	0.00539	CcSEcCtD
Sulfadiazine—Sepsis—Methotrexate—muscle cancer	0.0013	0.00536	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—muscle cancer	0.00124	0.00511	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—muscle cancer	0.00124	0.00511	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—muscle cancer	0.00122	0.00502	CcSEcCtD
Sulfadiazine—Vertigo—Vincristine—muscle cancer	0.00121	0.005	CcSEcCtD
Sulfadiazine—Leukopenia—Vincristine—muscle cancer	0.00121	0.00498	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00121	0.00498	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—muscle cancer	0.00119	0.0049	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—muscle cancer	0.00117	0.00485	CcSEcCtD
Sulfadiazine—Convulsion—Vincristine—muscle cancer	0.00117	0.00482	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00115	0.00475	CcSEcCtD
Sulfadiazine—Chills—Etoposide—muscle cancer	0.00113	0.00465	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—muscle cancer	0.00112	0.00464	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00112	0.00464	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00112	0.00463	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Vincristine—muscle cancer	0.0011	0.00454	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Vincristine—muscle cancer	0.00108	0.00445	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—muscle cancer	0.00107	0.00442	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—muscle cancer	0.00105	0.00434	CcSEcCtD
Sulfadiazine—Anorexia—Vincristine—muscle cancer	0.00105	0.00433	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—muscle cancer	0.00102	0.00422	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00101	0.00416	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.001	0.00414	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000996	0.00412	CcSEcCtD
Sulfadiazine—Insomnia—Vincristine—muscle cancer	0.000995	0.00411	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—muscle cancer	0.000981	0.00405	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000978	0.00404	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—muscle cancer	0.000977	0.00404	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—muscle cancer	0.000976	0.00403	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—muscle cancer	0.000973	0.00402	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—muscle cancer	0.000973	0.00402	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000971	0.00401	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000963	0.00398	CcSEcCtD
Sulfadiazine—Decreased appetite—Vincristine—muscle cancer	0.000956	0.00395	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00095	0.00392	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—muscle cancer	0.000946	0.00391	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—muscle cancer	0.00092	0.0038	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—muscle cancer	0.000907	0.00375	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vincristine—muscle cancer	0.000899	0.00372	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—muscle cancer	0.000891	0.00368	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—muscle cancer	0.000884	0.00365	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—muscle cancer	0.000872	0.0036	CcSEcCtD
Sulfadiazine—Abdominal pain—Vincristine—muscle cancer	0.00087	0.00359	CcSEcCtD
Sulfadiazine—Body temperature increased—Vincristine—muscle cancer	0.00087	0.00359	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—muscle cancer	0.000849	0.00351	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000847	0.0035	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—muscle cancer	0.000842	0.00348	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—muscle cancer	0.000834	0.00345	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00083	0.00343	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—muscle cancer	0.000816	0.00337	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vincristine—muscle cancer	0.00081	0.00335	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—muscle cancer	0.000797	0.00329	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—muscle cancer	0.000783	0.00323	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—muscle cancer	0.000781	0.00323	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—muscle cancer	0.000776	0.00321	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—muscle cancer	0.000775	0.0032	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000769	0.00318	CcSEcCtD
Sulfadiazine—Diarrhoea—Vincristine—muscle cancer	0.000753	0.00311	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—muscle cancer	0.000751	0.0031	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—muscle cancer	0.000731	0.00302	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—muscle cancer	0.000729	0.00301	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000718	0.00297	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—muscle cancer	0.00071	0.00293	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00071	0.00293	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—muscle cancer	0.000708	0.00292	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—muscle cancer	0.000706	0.00292	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—muscle cancer	0.000704	0.00291	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—muscle cancer	0.000704	0.00291	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—muscle cancer	0.0007	0.00289	CcSEcCtD
Sulfadiazine—Vomiting—Vincristine—muscle cancer	0.000699	0.00289	CcSEcCtD
Sulfadiazine—Rash—Vincristine—muscle cancer	0.000694	0.00287	CcSEcCtD
Sulfadiazine—Dermatitis—Vincristine—muscle cancer	0.000693	0.00286	CcSEcCtD
Sulfadiazine—Headache—Vincristine—muscle cancer	0.000689	0.00285	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—muscle cancer	0.000676	0.00279	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—muscle cancer	0.000674	0.00278	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—muscle cancer	0.000656	0.00271	CcSEcCtD
Sulfadiazine—Nausea—Vincristine—muscle cancer	0.000653	0.0027	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—muscle cancer	0.00065	0.00269	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—muscle cancer	0.00063	0.0026	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—muscle cancer	0.000615	0.00254	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—muscle cancer	0.00061	0.00252	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—muscle cancer	0.000606	0.00251	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—muscle cancer	0.000588	0.00243	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—muscle cancer	0.000585	0.00242	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—muscle cancer	0.000584	0.00241	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—muscle cancer	0.000567	0.00234	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—muscle cancer	0.000567	0.00234	CcSEcCtD
Sulfadiazine—Rash—Etoposide—muscle cancer	0.000562	0.00232	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—muscle cancer	0.000561	0.00232	CcSEcCtD
Sulfadiazine—Headache—Etoposide—muscle cancer	0.000558	0.00231	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—muscle cancer	0.000557	0.0023	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—muscle cancer	0.000534	0.00221	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—muscle cancer	0.000529	0.00219	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—muscle cancer	0.000523	0.00216	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—muscle cancer	0.000509	0.0021	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—muscle cancer	0.000509	0.0021	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—muscle cancer	0.000507	0.00209	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—muscle cancer	0.000491	0.00203	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000486	0.00201	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—muscle cancer	0.000483	0.00199	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—muscle cancer	0.000482	0.00199	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—muscle cancer	0.000464	0.00192	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000462	0.00191	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000461	0.0019	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000452	0.00187	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—muscle cancer	0.000441	0.00182	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000436	0.0018	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—muscle cancer	0.000424	0.00175	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—muscle cancer	0.000422	0.00174	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—muscle cancer	0.000422	0.00174	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000421	0.00174	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—muscle cancer	0.000418	0.00173	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—muscle cancer	0.000402	0.00166	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000399	0.00165	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—muscle cancer	0.000393	0.00162	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000378	0.00156	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—muscle cancer	0.000378	0.00156	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—muscle cancer	0.000367	0.00152	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—muscle cancer	0.000365	0.00151	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—muscle cancer	0.000365	0.00151	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—muscle cancer	0.000365	0.00151	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—muscle cancer	0.00034	0.00141	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—muscle cancer	0.000339	0.0014	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—muscle cancer	0.000337	0.00139	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—muscle cancer	0.000336	0.00139	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—muscle cancer	0.000334	0.00138	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—muscle cancer	0.000327	0.00135	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—muscle cancer	0.000317	0.00131	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—muscle cancer	0.000316	0.00131	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—muscle cancer	0.000294	0.00121	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—muscle cancer	0.000291	0.0012	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—muscle cancer	0.000291	0.0012	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—muscle cancer	0.00029	0.0012	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—muscle cancer	0.000275	0.00113	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—muscle cancer	4.59e-05	0.607	CrCbGaD
Sulfadiazine—Dapsone—PTGS2—muscle cancer	2.98e-05	0.393	CrCbGaD
